Dry eye disease: Pathophysiology, classification, and diagnosis

American Journal of Managed Care

Volumn 14, Issue SUPPL. 3, 2008, Pages

  Perry, Henry D ^a,b,c  

^a NORTH SHORE UNIVERSITY HOSPITAL   (United States)

^b OPHTHALMIC CONSULTANTS OF LONG ISLAND   (United States)

^c NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMIODARONE; ANTIANDROGEN; ANTIHISTAMINIC AGENT; ATROPINE; BENZALKONIUM CHLORIDE; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIPHENOXYLATE; DIURETIC AGENT; ESTROGEN; GESTAGEN; INTERFERON; ISOTRETINOIN; SPASMOLYTIC AGENT; TRICYCLIC ANTIDEPRESSANT AGENT;

ANATOMY; CONTACT LENS; DIABETES MELLITUS; DIAGNOSTIC PROCEDURE; DISEASE CLASSIFICATION; DRY EYE; ENVIRONMENTAL FACTOR; HORMONE ACTION; HUMAN; LACRIMAL APPARATUS; LACRIMAL DUCT; NUTRITION; OCCUPATION; PARKINSON DISEASE; PATHOPHYSIOLOGY; PHYSIOLOGY; PRIORITY JOURNAL; QUESTIONNAIRE; REFRACTIVE SURGERY; RETINOL DEFICIENCY; REVIEW; RISK FACTOR; SJOEGREN SYNDROME;

DRY EYE SYNDROMES; HUMANS;

EID: 43249111575     PISSN: 10880224     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (71)

1. Behrens A, Doyle JJ, Stern L, et al. Dysfunctional tear syndrome: a Delphi approach to treatment recommendations. Cornea. 2006;25:900-907.
2. Lemp MA. Report of the National Eye Institute/Industry Workshop on Clinical Trials in Dry Eyes. CLAO J. 1995;21:221-232.
3. The definition and classification of dry eye disease: report of the Definition and Classification Subcommittee of the International Dry Eye Workshop (2007). Ocul Surf. 2007;5:75-92. http://www.tearfilm.org/dewsreport/. Published April 2007. Accessed February 13, 2008.
4. Ohashi Y, Dogru M, Tsubota K. Laboratory findings in tear fluid analysis. Clin Chim Acta. 2006;369:17-28.
5. Montes-Mico R. Role of the tear film in the optical quality of the human eye. J Cataract Refract Surg. 2007;33:1631-1635.
6. Klenkler B, Sheardown H. Growth factors in the anterior segment: role in tissue maintenance, wound healing and ocular pathology. Exp Eye Res. 2004;79:677-688.
7. Dartt DA. Control of mucin production by ocular surface epithelial cells. Exp Eye Res. 2004;78:173-185.
8. American Optometric Association. Optometric clinical practice guideline: care of the patient with ocular surface disorders. http://www.aoa.org/documents/CPG-10.pdf. 2002, updates April and June 2003. Accessed February 13, 2008.
9. Gilbard JP. The diagnosis and management of dry eyes. Otolaryngol Clin North Am. 2005;38:871-885.
10. 2 nucleotide receptors in rabbit and human conjunctiva. Exp Eye Res. 1998;67:341-346.
11. Pflugfelder SC, Solomon A, Stern ME. The diagnosis and management of dry eye: a twenty-five year review. Cornea. 2000;19:644-649.
12. - and fluid secretion. Am J Physiol Cell Physiol. 2001;281:C595-C602.
13. Jones LT. The lacrimal secretory system and its treatment. Am J Ophthalmol. 1966;62:47-60.
14. Jordan A, Baum J. Basic tear flow. Does it exist? Ophthalmology. 1980;87:920-930.
15. Stem ME, Beuerman RW, Fox RI, Gao J, Mircheff AK, Pflugfelder SC. The pathology of dry eye: the interaction between the ocular surface and lacrimal glands. Cornea. 1998;17:584-589.
16. Ubels JL, Foley KM, Rismondo V. Retinol secretion by the lacrimal gland. Invest Ophthalmol Vis Sci. 1986;27:1261-1268.
17. Geerling G, MacLennan S, Hartwig D. Autologous serum eye drops for ocular surface disorders. Br J Ophthalmol. 2004;88:1467-1474.
18. Foulks GN. The correlation between the tear film lipid layer and dry eye disease. Surv Ophthalmol. 2007;52:369-374.
19. Bron AJ, Tiffany JM, Gouveia SM, Yokoi N, Voon LW. Functional aspects of the tear film lipid layer. Exp Eye Res. 2004;78:347-360.
20. American Academy of Ophthalmology. Preferred practice pattern: dry eye syndrome. http://www.aao.org/education/guidelines/ppp/upload/ Dry_Eye_Syndrome-2.pdf. Published 2003. Accessed February 13, 2008.
21. Diller R, Sant S. A case report and review of filamentary keratitis. Optometry. 2005;76:30-36.
22. Albietz J, Sanfilippo P, Troutbeck R, Lenton LM. Management of filamentary keratitis associated with aqueous-deficient dry eye. Optom Vis Sci. 2003;80:420-430.
23. McMonnies CW. Incomplete blinking: exposure keratopathy, lid wiper epitheliopathy, dry eye, refractive surgery, and dry contact lenses. Cont Lens Anterior Eye. 2007;30:37-51.
24. Sarver MD, Nelson JL, Polse KA. Peripheral corneal staining accompanying contact lens wear. J Am Optom Assoc. 1969;40:310-313.
25. Shimazaki J, Goto E, Ono M, Shimmura S, Tsubota K. Meibomian gland dysfunction in patients with Sjögren syndrome. Ophthalmology. 1998;105:1485-1488.
26. The epidemiology of dry eye disease: report of the Epidemiology Subcommittee of the International Dry Eye Workshop (2007). Ocul Surf. 2007;5:93-107. http://www.tearfilm.org/dewsreport/. Published April 2007. Accessed February 13, 2008.
27. Wolkoff P, Nojgaard JK, Troiano P, Piccoli B. Eye complaints in the office environment: precorneal tear film integrity influenced by eye blinking efficiency. Occup Environ Med. 2005;62:4-12.
28. Blehm C, Vishnu S, Khattak A, Mitra S, Yee RW. Computer vision syndrome: a review. Surv Ophthalmol. 2005;50:253-262.
29. Miljanovic B, Trivedi KA, Dana MR, Gilbard JP, Buring JE, Schaumberg DA. Relation between dietary n-3 and n-6 fatty acids and clinically diagnosed dry eye syndrome in women. Am J Clin Nutr. 2005;82:887-893.
30. Sullivan DA, Sullivan BD, Evans JE, et al. Androgen deficiency, meibomian gland dysfunction, and evaporative dry eye. Ann N Y Acad Sci. 2002;966:211-222.
31. Sullivan DA. Tearful relationships? Sex, hormones, the lacrimal gland, and the aqueous-deficient dry eye. Ocul Surf. 2004;2:92-123.
32. Moss SE, Klein R, Klein BE. Incidence of dry eye in an older population. Arch Ophthalmol. 2004;122:369-373.
33. Bozkurt B, Irkeç MT, Atakan N, Orhan M, Geyik PÖ. Lacrimal function and ocular complications in patients treated with systemic isotretinoin. Eur J Ophthalmol. 2002;12:173-176.
34. Aragona P, Cannavo SP, Borgia F, Guarneri F. Utility of studying the ocular surface in patients with acne vulgaris treated with oral isotretinoin: a randomized controlled trial. [letter] Br J Dermatol. 2005;152:576-578.
35. Ikäheimo K, Kettunen R, Mäntyjärvi M. Visual functions and adverse ocular effects in patients with amiodarone medication. Acta Ophthalmol Scand. 2002;80:59-63.
36. Kerin NZ, Aragon E, Faitel K, Frumin H, Rubenfire M. Long-term efficacy and toxicity of high- and low-dose amiodarone regimens. J Clin Pharmacol. 1989;29:418-423.
37. Greene HL, Graham EL, Werner JA, et al. Toxic and therapeutic effects of amiodarone in the treatment of cardiac arrhythmias. J Am Coll Cardiol. 1983;2:1114-1128.
38. Cotler SJ, Wartelle CF, Larson AM, Gretch DR, Jensen DM, Carithers RL Jr. Pretreatment symptoms and dosing regimen predict side-effects of interferon therapy for hepatitis C. J Viral Hepat. 2000;7:211-217.
39. Huang FC, Shih MH, Tseng SH, Lin SC, Chang TT. Tear function changes during interferon and ribavirin treatment in patients with chronic hepatitis C. Cornea. 2005;24:561-566.
40. Schaumberg DA, Buring JE, Sullivan DA, Dana MR. Hormone replacement therapy and dry eye syndrome. JAMA. 2001;286:2114-2119.
41. Management and therapy of dry eye disease: report of the Management and Therapy Subcommittee of the International Dry Eye Workshop (2007). Ocul Surf. 2007;5:163-178. http://www.tearfilm.org/dewsreport/. Published April 2007. Accessed February 13, 2008.
42. Albietz JM, Lenton LM, McLennan SG. Chronic dry eye and regression after laser in situ keratomileusis for myopia. J Cataract Refract Surg. 2004;30:675-684.
43. Kaiserman I, Kaiserman N, Nakar S, Vinker S. Dry eye in diabetic patients. Am J Ophthalmol. 2005;139:498-503.
44. Hom M, De Land P. Self-reported dry eyes and diabetic history. Optometry. 2006;77:554-558.
45. Methodologies to diagnose and monitor dry eye disease: report of the Diagnostic Methodology Subcommittee of the International Dry Eye Workshop (2007). Ocul Surf. 2007;5:108-152. http://www.tearfilm.org/dewsreport/. Published April 2007. Accessed February 13, 2008.
46. Anzaar F, Foster CS, Ekong AS. Dry eye syndrome. eMedicine. http://www.emedicine.com/oph/topic597.htm. Updated August 25, 2006. Accessed February 13, 2008.
47. Nichols KK, Nichols JJ, Mitchell GL. The lack of association between signs and symptoms in patients with dry eye disease. Cornea. 2004;23:762-770.
48. Schiffman RM, Christiansen MD, Jacobsen G, Hirsch JD, Reis BL. Reliability and validity of the Ocular Surface Disease Index. Arch Ophthalmol. 2000;118:615-621.
49. Ocular Surface Disease Index (OSDI). Allergan, 2004. http://www. restasisprofessional.com/documents/OSDI_PAD.pdf. Accessed February 13, 2008.
50. Nichols KK, Nichols JJ, Mitchell GL. The reliability and validity of McMonnies Dry Eye Index. Cornea. 2004;23:365-371.
51. Doughty MJ, Fonn D, Richter D, Simpson T, Caffery B, Gordon K. A patient questionnaire approach to estimating the prevalence of dry eye symptoms in patients presenting to optometric practices across Canada. Optom Vis Sci. 1997;74:624-631.
52. Oden NL, Lilienfeld DE, Lemp MA, Nelson JD, Ederer F. Sensitivity and specificity of a screening questionnaire for dry eye. Adv Exp Med Biol. 1998;438:807-820.
53. Schaumberg DA, Sullivan DA, Buring JE, Dana MR. Prevalence of dry eye syndrome among US women. Am J Ophthalmol. 2003;136:318-326.
54. Mangione CM, Lee PP, Pitts J, Gutierrez P, Berry S, Hays RD; for the National Eye Institute Visual Function Questionnaire Field Test Investigators. Psychometric properties of the National Eye Institute Visual Function Questionnaire (NEI-VFQ). Arch Ophthalmol. 1998;116:1496-1504.
55. Mangione CM, Lee PP, Gutierrez PR, et al. Development of the 25-item National Eye Institute Visual Function Questionnaire. Arch Ophthalmol. 2001;119:1050-1058.
56. Visual Function Questionnaire (VFQ-25). Rand, 2000. http://www.rand.org/ health/surveys_tools/vfq/. Accessed February 13, 2008.
57. Dry Eye Questionnaire. Indiana University, 2002. http://research.opt. indiana.edu/Labs/CorneaContactLens/DEQ.pdf. Accessed February 13, 2008.
58. Begley CG, Caffery B, Chalmers RL, Mitchell GL; Dry Eye Investigation (DREI) Study Group. Use of the Dry Eye Questionnaire to measure symptoms of ocular irritation in patients with aqueous tear deficient dry eye. Cornea. 2002;21:664-670.
59. Begley CG, Caffery B, Nichols KK, Chalmers R. Responses of contact lens wearers to a dry eye survey. Optom Vis Sci. 2000;77:40-46.
60. Begley CG, Chalmers RL, Abetz L, et al. The relationship between habitual patient-reported symptoms and clinical signs among patients with dry eye of varying severity. Invest Ophthalmol Vis Sci. 2003;44:4753-4761.
61. Begley CG, Chalmers RL, Mitchell GL, et al. Characterization of ocular surface symptoms from optometric practices in North America. Cornea. 2001;20:610-618.
62. Cross WD, Lay LF Jr, Walt JG, Kozma CM. Clinical and economic implications of topical cyclosporin A for the treatment of dry eye. Manag Care Interface. 2002;15:44-49.
63. Hirsch JD, Kozma CM, Wojcik AR, Reis B. Economic and quality-of-life impact of dry eye symptoms: a Sjögren's syndrome patient survey. Invest Ophthalmol Vis Sci. 1998;39:S65.
64. Johnson ME, Murphy PJ. Measurement of ocular surface irritation on a linear interval scale with the Ocular Comfort Index. Invest Ophthalmol Vis Sci. 2007;48:4451-4458.
65. Tsubota K. Tear dynamics and dry eye. Prog Retin Eye Res. 1998;17:565-596.
66. Afonso AA, Monroy D, Stern ME, Feuer WJ, Tseng SC, Pflugfelder SC. Correlation of tear fluorescein clearance and Schirmer test scores with ocular irritation symptoms. Ophthalmology. 1999;106:803-810.
67. de Paiva CS, Lindsey JL, Pflugfelder SC. Assessing the severity of keratitis sicca with videokeratoscopic indices. Ophthalmology. 2003;110:1102-1109.
68. Huang FC, Tseng SH, Shih MH, Chen FK. Effect of artificial tears on corneal surface regularity, contrast sensitivity, and glare disability in dry eyes. Ophthalmology. 2002;109:1934-1940.
69. Goto T, Zheng X, Klyce SD, et al. Evaluation of the tear film stability after laser in situ keratomileusis using the tear film stability analysis system. Am J Ophthalmol. 2004;137:116-120.
70. Calonge M, Diebold Y, Saez V, et al. Impression cytology of the ocular surface: a review. Exp Eye Res. 2004;78:457-472.
71. Nichols KK, Mitchell GL, Zadnik K. The repeatability of clinical measurements of dry eye. Cornea. 2004;23:272-285.